Therapeutic strategies for hepatitis B virus infection: towards a cure

GC Fanning, F Zoulim, J Hou, A Bertoletti - Nature reviews Drug …, 2019 - nature.com
Chronic hepatitis B virus (HBV) infection is a common cause of liver disease globally, with a
disproportionately high burden in South-East Asia. Vaccines and nucleoside or nucleotide …

Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities

RG Gish, BD Given, CL Lai, SA Locarnini, JYN Lau… - Antiviral research, 2015 - Elsevier
The host immune system plays an important role in chronic hepatitis B (CHB), both in viral
clearance and hepatocellular damage. Advances in our understanding of the natural history …

Targeting innate and adaptive immune responses to cure chronic HBV infection

AJ Gehring, U Protzer - Gastroenterology, 2019 - Elsevier
Fewer than 1% of chronic hepatitis B virus infections per year are cured with antiviral
treatment. This creates a need for long-term treatment, which poses challenges for patients …

[PDF][PDF] Hepatitis B cure: from discovery to regulatory approval

AS Lok, F Zoulim, G Dusheiko, MG Ghany - Hepatology, 2017 - Wiley Online Library
The majority of persons currently treated for chronic hepatitis B require long‐term or lifelong
therapy. New inhibitors of hepatitis B virus entry, replication, assembly, or secretion and …

Current best practice in hepatitis B management and understanding long-term prospects for cure

D Yardeni, KM Chang, MG Ghany - Gastroenterology, 2023 - Elsevier
The hepatitis B virus (HBV) is a major cause of cirrhosis and hepatocellular carcinoma
worldwide. Despite an effective vaccine, the prevalence of chronic infection remains high …